An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
Market Analysis and Insights: Global and United States Continuous Subcutaneous Insulin Infusion Therapy Market
This report focuses on global and United States Continuous Subcutaneous Insulin Infusion Therapy market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Continuous Subcutaneous Insulin Infusion Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Normal accounting for % of the Continuous Subcutaneous Insulin Infusion Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Continuous Subcutaneous Insulin Infusion Therapy market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Continuous Subcutaneous Insulin Infusion Therapy Scope and Market Size
Continuous Subcutaneous Insulin Infusion Therapy market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Continuous Subcutaneous Insulin Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Continuous Subcutaneous Insulin Infusion Therapy market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Continuous Subcutaneous Insulin Infusion Therapy market is segmented into
Normal
Patch Pump
Segment by Application, the Continuous Subcutaneous Insulin Infusion Therapy market is segmented into
Hospital
Retail Pharmacy
Other
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Continuous Subcutaneous Insulin Infusion Therapy Market Share Analysis
Continuous Subcutaneous Insulin Infusion Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Continuous Subcutaneous Insulin Infusion Therapy business, the date to enter into the Continuous Subcutaneous Insulin Infusion Therapy market, Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Table of Contents
1 Study Coverage
1.1 Continuous Subcutaneous Insulin Infusion Therapy Revenue in Continuous Subcutaneous Insulin Infusion Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global Continuous Subcutaneous Insulin Infusion Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size for the Year 2017-2028
1.2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size for the Year 2017-2028
1.3 Continuous Subcutaneous Insulin Infusion Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Continuous Subcutaneous Insulin Infusion Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Continuous Subcutaneous Insulin Infusion Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
Summary: Get latest Market Research Reports on Continuous Subcutaneous Insulin Infusion Therapy. Industry analysis & Market Report on Continuous Subcutaneous Insulin Infusion Therapy is a syndicated market report, published as Global and United States Continuous Subcutaneous Insulin Infusion Therapy Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Continuous Subcutaneous Insulin Infusion Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.